Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma - sprookjes - yvandenbroek - TriplyDB

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

http://www.wikidata.org/entity/Q28181979

about

Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells Prognostic value of proliferation in invasive breast cancer: a review Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression Role of hypoxia-inducible factors in breast cancer metastasis Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis Artificial ligand binding within the HIF2 PAS-B domain of the HIF2 transcription factor Principles of Ligand Binding within a Completely Buried Cavity in HIF2α PAS-B Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor Implications of Hypoxia in Breast Cancer Metastasis to Bone Hypoxia-inducible factor 1 and breast cancer metastasis Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells Digoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1α under hypoxic conditions in human lung adenocarcinoma A549 cells Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1.Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha.Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).Building pathway clusters from Random Forests classification using class votes Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy.Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4 Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.Hypoxia-specific targets in cancer therapy: role of splice variants Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.Active HIF-1 in the normal human retina FBP1 expression is associated with basal-like breast carcinoma Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis.Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro.Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.

P2860

Q24613508-338C1A6A-43EC-4112-8084-832B049ABFB9 Q24672660-94CAFEA5-3032-4D60-B2FE-AD46ADE069EE Q24794814-660E421B-23BD-47EB-BC6B-8D50370B95AD Q24806403-9089FF9E-5049-475C-81ED-A514ED37BF6A Q24813750-0B2CEA62-2B22-4E48-851F-0586F0314495 Q24815236-7D13B846-AFE5-4EAD-BBEE-627758BE801E Q25255387-3CB70023-F067-4EB6-9DD0-00F8A6DFEAEC Q26767514-E0500A09-0CA6-43E9-9D59-3A046744F46E Q26860122-08A8F2F2-ECF0-499F-964D-DFB6146EE041 Q26866144-427CB319-5ECC-4ABE-BBD3-D5DC16D47692 Q27653363-64A81899-AEAD-43E4-9B74-14C1F0C2C577 Q27658400-0F8F17EC-A32A-4952-9783-8686C7B70A02 Q27676058-ECC53909-153B-4423-9428-557EFACA2CFD Q28077444-69B7360C-92F2-415E-AAC8-1A9342760BDE Q28087393-57DE9DEB-C3EF-4A24-B70C-EFF0A0D86BC9 Q28393898-5FC00F6C-5668-4CA8-89B4-60A5745DA50D Q28397747-D293FD00-40FE-4118-8160-1A03D55DC7D3 Q29615944-7D387D8B-E7BB-4DE6-B645-7EA39BA118B5 Q30484945-40415985-4A8D-4661-AACA-F51749A8D80B Q30838633-D677B182-C1E5-452B-9776-7624C7038690 Q30992467-DAA4C4B2-BC1E-4D8A-9EA0-67E15ED3B9A6 Q33234082-7F464518-783B-4EE0-A78D-9E51AB927ADD Q33235403-B52CFCC1-C2E6-4F09-B126-ED77DA8CD727 Q33318578-EEDD8D1D-DADE-4BA6-A884-9BA98FD4E99E Q33463900-2F1429EA-138C-4FB6-B9A5-FB655208CFC3 Q33508581-A627DE18-24E4-4225-91A3-DBC05619F882 Q33517893-190AFCF7-5C4F-4780-8EE0-9DBA2CE44105 Q33555302-A8B653A3-E1D1-4A66-B87F-B1B31D506EE9 Q33584212-FCE51FDE-F34B-446F-BF0E-274BC65C1E28 Q33611310-612C73E3-DEC9-446D-A69D-AC12BB81A2D4 Q33630837-3CEEF82D-08DD-432E-876C-ADB535320D3F Q33656653-ED5F02FB-9A8E-440D-8B76-5C8ECBE7577D Q33665254-BF1C760F-97C3-46BA-B669-8D621F2D305E Q33673946-761DA8E3-9CFC-474B-B12F-E9DAE35D4029 Q33686009-D3567900-E24B-4119-8DD0-E7D20515CA19 Q33743421-1010172F-21A4-43E3-BF09-4B43C060785D Q33816341-01882918-4431-4025-9578-C94C2445E7A5 Q33829094-E88FB1C5-45AE-40CF-B4EF-2FDEC9B5FA29 Q33888179-D52CBC50-322A-47A6-B61E-0DFE18E0A9C5 Q33968437-3F74AC7B-B0F5-4622-B14E-F191AE0664A1

P2860

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

http://www.wikidata.org/entity/Q28181979

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@ast

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@en

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@nl

type

label

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@ast

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@en

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@nl

prefLabel

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@ast

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@en

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@nl

P1433

Q28181979-4B00CCD3-10B5-4116-89C8-80F70FE3DDB3

P1476

Q28181979-69C5CD64-ECDF-4E42-9630-2B92E182071E

P2093

Q28181979-03F3794A-D0AE-4185-8EB0-C6EF0A92CB42

Q28181979-5F753A7C-BC24-4E62-945B-8AE50213DA57

Q28181979-86007C18-905D-437A-8A10-6316B66D3CD4

Q28181979-9F4F5CC0-784F-4B97-B025-D12282F7DB5D

Q28181979-A3C5BF80-DADE-429C-81F8-F769B1D44DF0

Q28181979-BDADEE3E-1804-4142-A91A-D2AC7EDECEBC

Q28181979-C53765AD-1DD3-4BD3-9FD9-4502DCAC8282

Q28181979-DBBF0CD4-29DD-4528-98A8-EA634D83D9D6

P304

Q28181979-0C7AF32A-0B8F-4794-87FA-5B100B8E55F0

P31

Q28181979-CC142C0A-4AC6-45EC-AE3B-7D0D2686BEB6

P3181

Q28181979-9CAA5CA2-A20C-4974-8961-2B1A981E11EA

P356

Q28181979-B8208BAE-A705-4AD5-B87F-C6286B0B18FB

P407

Q28181979-C22253C8-D7A9-4141-9BE3-A9FF0A071D55

P433

Q28181979-46445966-9C7E-406D-A55A-C24C3CF671C7

P478

Q28181979-496C4DC4-B2C6-493E-8246-FCDCA0EF3009

P50

Q28181979-A9808C51-1989-41D5-A775-E47C89986BFE

P577

Q28181979-94B0DB03-AFD8-4F84-9666-16F977D1B48E

P698

Q28181979-1350C363-9A0F-412A-9F5B-D84F23DAB5D4

P921

Q28181979-22538523-F023-4AF4-84B6-91BA9B30B316

Q28181979-CCF791DF-FB25-4381-8412-390E2734DF3E

P3181

P356

P1433

P1476

Levels of hypoxia-inducible fa ...... node negative breast carcinoma

@en

P2093

Astrid E Greijer

http://www.w3.org/2001/XMLSchema#string

Avi Shvarts

http://www.w3.org/2001/XMLSchema#string

Elsken van der Wall

http://www.w3.org/2001/XMLSchema#string

Herbert M Pinedo

http://www.w3.org/2001/XMLSchema#string

Paul J van Diest

http://www.w3.org/2001/XMLSchema#string

Petra van der Groep

http://www.w3.org/2001/XMLSchema#string

Reinhard Bos

http://www.w3.org/2001/XMLSchema#string

Sybren Meijer

http://www.w3.org/2001/XMLSchema#string

P304

1573-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3246815

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/CNCR.11246

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Gregg L. Semenza

P577

2003-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12627523

http://www.w3.org/2001/XMLSchema#string

P921